Pedal power: could a bike ride supercharge Cancer-Fighting cells?
NCT ID NCT06643221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study explores whether exercise can improve the quality of immune cells collected from healthy donors for blood cancer treatments. Researchers will have healthy volunteers cycle, take a beta blocker or placebo, or receive a drug that mimics adrenaline, then analyze their blood cells in the lab and in mice. The goal is to see if exercise-induced changes make cell therapies more effective and reduce harmful side effects like graft-versus-host disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- exercise and isoproterenol
- What this could lead to
- If successful, this could point toward a simple way to collect better immune cells from donors, potentially making cell therapies for blood cancer more effective and reducing side effects like graft-versus-host disease.
- What could go wrong
- This is a very early, small study in healthy volunteers, not patients. It only tests lab and animal effects, so it may not translate to real patient benefits. The drug isoproterenol can cause heart-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAR-T CELL THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Arizona
RECRUITINGTucson, Arizona, 85719, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can engineered immune cells tackle brain lymphoma?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A simple blood test may reveal hidden infertility risk in young cancer survivors